Is Buying Baxter International Inc (NYSE:BAX), Having Lower Short Interest a Winning Strategy?

May 17, 2018 - By Harriett Tippett

Baxter International Inc. (NYSE:BAX) Logo

Investors sentiment is 0.97 in 2017 Q4. Its the same as in 2017Q3. It has no change, as 32 investors sold Baxter International Inc. shares while 311 reduced holdings. only 81 funds opened positions while 250 raised stakes. 441.20 million shares or 0.32% more from 439.80 million shares in 2017Q3 were reported.
Robeco Institutional Asset Management Bv invested in 0.84% or 2.53M shares. Tarbox Family Office owns 1,293 shares for 0.03% of their portfolio. Alliancebernstein L P reported 864,931 shares. Btim holds 0% in Baxter International Inc. (NYSE:BAX) or 4,590 shares. Signaturefd Limited Liability Company has 5,886 shares. Carlson Cap Management owns 0.06% invested in Baxter International Inc. (NYSE:BAX) for 3,321 shares. Greenleaf stated it has 6,701 shares or 0.01% of all its holdings. Capital Lc invested in 0% or 102 shares. Old Mutual Customised Solutions (Proprietary) Limited owns 10,688 shares. Roberts Glore & Incorporated Il has invested 0.23% of its portfolio in Baxter International Inc. (NYSE:BAX). Highlander Capital Mgmt Ltd Co has 2,650 shares. Ccm Inv Advisers Llc stated it has 1.78% of its portfolio in Baxter International Inc. (NYSE:BAX). State Of Wisconsin Inv Board has 430,086 shares. Zacks Inv has 305,464 shares. The North Carolina-based First Citizens Commercial Bank has invested 0.42% in Baxter International Inc. (NYSE:BAX).

Since March 2, 2018, it had 0 buys, and 5 sales for $5.13 million activity. 3,760 shares valued at $243,443 were sold by STROUCKEN ALBERT P L on Monday, April 2. The insider HELLMAN PETER S sold 3,760 shares worth $243,408. Another trade for 47,959 shares valued at $3.10 million was sold by STORM KORNELIS J.. Shapazian Carole J sold $329,590 worth of stock or 4,990 shares.

The stock of Baxter International Inc (NYSE:BAX) registered a decrease of 25.31% in short interest. BAX’s total short interest was 5.73 million shares in May as published by FINRA. Its down 25.31% from 7.67 million shares, reported previously. With 3.32 million shares average volume, it will take short sellers 2 days to cover their BAX’s short positions. The short interest to Baxter International Inc’s float is 1.13%.

The stock decreased 0.30% or $0.21 during the last trading session, reaching $70.53. About 1.01M shares traded. Baxter International Inc. (NYSE:BAX) has risen 25.16% since May 17, 2017 and is uptrending. It has outperformed by 13.61% the S&P500.

Baxter International Inc. provides a portfolio of renal and hospital products. The company has market cap of $37.77 billion. The firm operates through two divisions, Hospital Products and Renal. It has a 54.8 P/E ratio. The Hospital Products segment makes intravenous solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, parenteral nutrition therapies, infusion pumps, inhalation anesthetics, and biosurgery products.

Baxter International Inc. (NYSE:BAX) Ratings Coverage

Among 12 analysts covering Baxter International (NYSE:BAX), 7 have Buy rating, 0 Sell and 5 Hold. Therefore 58% are positive. Baxter International had 17 analyst reports since November 22, 2017 according to SRatingsIntel. BMO Capital Markets maintained it with “Buy” rating and $74.0 target in Tuesday, December 12 report. The rating was maintained by Stifel Nicolaus on Monday, April 30 with “Hold”. Citigroup maintained the stock with “Neutral” rating in Monday, April 30 report. The stock of Baxter International Inc. (NYSE:BAX) has “Hold” rating given on Thursday, February 1 by RBC Capital Markets. As per Tuesday, February 6, the company rating was maintained by Citigroup. On Monday, February 5 the stock rating was maintained by Stifel Nicolaus with “Hold”. The stock has “Outperform” rating by Raymond James on Wednesday, January 3. On Tuesday, February 20 the stock rating was upgraded by Deutsche Bank to “Buy”. The rating was maintained by BMO Capital Markets on Thursday, February 1 with “Buy”. The stock has “Overweight” rating by JP Morgan on Tuesday, January 2.

More notable recent Baxter International Inc. (NYSE:BAX) news were published by: Streetinsider.com which released: “Loeb’s Third Point LLC Enters Adobe (ADBE), EA (EA), Wynn (WYN) (more…) – 13F” on May 15, 2018, also Seekingalpha.com with their article: “Baxter Is Quickly Rebuilding Its Solid Dividend” published on May 17, 2018, Streetinsider.com published: “Baxter (BAX) Announces US FDA Clearance of New Spectrum IQ Infusion System” on May 14, 2018. More interesting news about Baxter International Inc. (NYSE:BAX) were released by: Seekingalpha.com and their article: “Premarket analyst action – healthcare” published on May 17, 2018 as well as Streetinsider.com‘s news article titled: “Piper Jaffray Assumes Baxter International (BAX) at Overweight” with publication date: May 17, 2018.

Baxter International Inc. (NYSE:BAX) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: